Related Experiment Video
Updated: Sep 8, 2025
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Magnetic resonance imaging of a temporal lobe cerebral amyloidoma
Jack Ogilvie1, Raymond Zhao2, Sandra Camelo-Piragua3
1Department of Radiology, Henry Ford Hospital, 2799 E Grand Blvd, Detroit, MI 48202, USA.
Abstract:
Amyloidomas are focal solitary amyloid masses without systemic involvement that have been observed to occur in various body locations. When presenting intracranially, they pose a challenging diagnostic and therapeutic course given their location and rarity. We report a case of a 62-year-old man with a 4-year history of seizure and headaches. Magnetic resonance imaging was initially inconclusive but revealed an ill-defined right temporal lobe lesion. Biopsy later confirmed a cerebral amyloidoma. We also review the current literature on the pathogenesis, imaging findings, prognosis, and treatment of cerebral amyloidomas.
Insights
Cerebral amyloidomas are rare, solitary amyloid masses in the brain. This case highlights the diagnostic challenges and reviews current literature on these unusual intracranial lesions.
Area of Science:
- Neurology
- Pathology
Background:
- Amyloidomas are focal, solitary amyloid deposits without systemic disease.
- Intracranial amyloidomas present diagnostic and therapeutic challenges due to rarity and location.
Observation:
- A 62-year-old male presented with a 4-year history of seizures and headaches.
- Initial MRI showed an ill-defined right temporal lobe lesion, which was inconclusive.
- Biopsy confirmed the diagnosis of a cerebral amyloidoma.
Findings:
- Cerebral amyloidomas are rare intracranial masses.
- Diagnosis can be challenging, often requiring biopsy confirmation.
- Literature review covers pathogenesis, imaging, prognosis, and treatment.
Implications:
- This case underscores the importance of considering cerebral amyloidoma in the differential diagnosis of temporal lobe lesions.
- Further research into optimal diagnostic and therapeutic strategies for cerebral amyloidomas is warranted.
- Understanding the characteristics of cerebral amyloidomas can improve patient outcomes.
